OrbiMed’s State Street SPDR S&P 500 ETF Trust SPY Stock Holding History

OrbiMed’s Portfolio SPY Stock Details SPY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-300,000	Closed	-$53.1M	–	134
2013 Q3	$50.4M	Buy	+300,000	New	+$50.3M	0.9%	34

Other funds holding SPY

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

OrbiMed's SPY Position: Q4 2013 in Review

OrbiMed sold out of State Street SPDR S&P 500 ETF Trust (SPY) in Q4 2013, closing a stake of 300,000 shares — an estimated $53.1M sold.

OrbiMed first reported a position in SPY in Q3 2013 and held it in 1 quarter. The position peaked at $50.4M in Q3 2013. 1,211 funds tracked by Wall St. Rank hold SPY as of Q4 2013.

OrbiMed reported no remaining State Street SPDR S&P 500 ETF Trust position as of Q4 2013 after selling out during the quarter.
OrbiMed sold 300,000 State Street SPDR S&P 500 ETF Trust shares in Q4 2013, an estimated $53.1M.
OrbiMed first reported a position in State Street SPDR S&P 500 ETF Trust in Q3 2013 and held it in 1 quarter.
OrbiMed's State Street SPDR S&P 500 ETF Trust position peaked at $50.4M in Q3 2013.
1,211 funds tracked by Wall St. Rank held State Street SPDR S&P 500 ETF Trust as of Q4 2013.

Based on OrbiMed's 13F filing for Q4 2013, filed 14 Feb 2014.